Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis

被引：0
|
作者：
Fan, Shule [1 ]
Wan, Zeyi [1 ]
Qu, Yuhua [1 ]
Lu, Wenxia [1 ]
Li, Xiangzhi [1 ]
Yang, Feifei [1 ]
Zhang, Hua [1 ]
机构：
[1] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Shandong Provin, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2024年 / 114卷
基金：
中国国家自然科学基金;
关键词：
Tetrahydro-beta-carboline; Hydroxamate; HDAC inhibitors; Antitumor;
D O I：
10.1016/j.bmcl.2024.129986
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Histone deacetylases (HDACs) are validated drug targets for various therapeutic applications. A series of Tetrahydro-beta-carboline-based hydroxamate derivatives, designed as HDAC inhibitors (HDACis), were synthesized. Compound 11g exhibited strong inhibitory activity against HDAC1 and the A549 cancer cell line. Additionally, this compound increased the levels of acetylated histone H3 and H4. Notably, 11g effectively arrested A549 cells in the G2/M phase and also increased ROS production and DNA damage, thereby inducing apoptosis. Further molecular docking experiments illustrated the potential interactions between compound 11g and HDAC1. These findings suggested that the novel Tetrahydro-beta-carboline-based HDACis could serve as a promising framework for further optimization as anticancer agents.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Enantioselective synthesis and biological investigation of tetrahydro-β-carboline-based HDAC6 inhibitors with improved solubility
    Gruenstein, Elisabeth
    Sellmer, Andreas
    Mahboobi, Siavosh
    ARCHIV DER PHARMAZIE, 2019, 352 (06)
  • [2] Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stability
    Scheuerer, Simon
    Motlova, Lucia
    Schaeker-Huebner, Linda
    Sellmer, Andreas
    Feller, Felix
    Ertl, Fabian J.
    Koch, Pierre
    Hansen, Finn K.
    Barinka, Cyril
    Mahboobi, Siavosh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 276
  • [3] Design, synthesis, and biological evaluation of novel C3-sustituted β-carboline-based HDAC inhibitors with potent antitumor activities
    Ling, Yong
    Feng, Jiao
    Miao, Jiefei
    Guo, Jing
    Peng, Yanfu
    Zhang, Yanan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [4] Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4
    Jenkins, Paul R.
    Wilson, James
    Emmerson, Daniel
    Garcia, Marcos D.
    Smith, Matthew R.
    Gray, Stephen J.
    Britton, Robert G.
    Mahale, Sachin
    Chaudhuri, Bhabatosh
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (16) : 7728 - 7739
  • [5] Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors
    Leonhardt, Michel
    Sellmer, Andreas
    Kraemer, Oliver H.
    Dove, Stefan
    Elz, Sigurd
    Kraus, Birgit
    Beyer, Mandy
    Mahboobi, Siavosh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 152 : 329 - 357
  • [6] Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells
    Ling, Yong
    Guo, Jing
    Yang, Qiuxing
    Zhu, Peng
    Miao, Jiefei
    Gao, Weijie
    Peng, Yanfu
    Yang, Jiaying
    Xu, Kun
    Xiong, Biao
    Liu, Gongqing
    Tao, Jinhua
    Luo, Lin
    Zhu, Qing
    Zhang, Yanan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 398 - 409
  • [7] Design and Synthesis of C3-Substituted β-Carboline-Based Histone Deacetylase Inhibitors with Potent Antitumor Activities
    Ling, Yong
    Feng, Jiao
    Luo, Lin
    Guo, Jing
    Peng, Yanfu
    Wang, Tingting
    Ge, Xiang
    Xu, Qibing
    Wang, Xinyang
    Dai, Hong
    Zhang, Yanan
    CHEMMEDCHEM, 2017, 12 (09) : 646 - 651
  • [8] Design and Optimization of Novel Hydroxamate-Based Histone Deacetylase Inhibitors of Bis-Substituted Aromatic Amides Bearing Potent Activities against Tumor Growth and Metastasis
    Yang, Feifei
    Zhang, Tao
    Wu, Haigang
    Yang, Yang
    Liu, Ning
    Chen, Ang
    Li, Qiang
    Li, Jingjie
    Qin, Liwen
    Jiang, Beier
    Wang, Xin
    Pang, Xiufeng
    Yi, Zhengfang
    Liu, Mingyao
    Chen, Yihua
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9357 - 9369
  • [9] Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities
    Liu, Ji
    Wang, Tingting
    Wang, Xinyang
    Luo, Lin
    Guo, Jing
    Peng, Yanfu
    Xu, Qibing
    Miao, Jiefei
    Zhang, Yanan
    Ling, Yong
    MEDCHEMCOMM, 2017, 8 (06) : 1213 - 1219
  • [10] Designing of new tetrahydro-β-carboline-based ABCG2 inhibitors using 3D-QSAR, molecular docking, and DFT tools
    Ahmad, Shahnawaz
    Gupta, Dinesh
    Ahmed, Tanzeel
    Islam, Asimul
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23): : 14016 - 14027
12345